Clinical Trials on Immune Thrombocytopenia

Total 51063 results

Ostfold Hospital Trust
Oslo University Hospital; South-Eastern Regional Health Authority

Completed

Rituximab as Second Line Treatment for ITP

Immune Thrombocytopenia (ITP)

Norway
University Hospital, Bordeaux

Completed

Diagnostic of Chronic Thrombocytopenia (DIATROC)

Chronic Idiopathic Thrombocytopenic Purpura | Congenital Thrombocytopenia
Novartis Pharmaceuticals

Completed

EXTEND (Eltrombopag Extended Dosing Study) (EXTEND)

Purpura, Thrombocytopaenic, Idiopathic

United Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
Eisai Inc.

Completed

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Immune Thrombocytopenia | Chronic Thrombocytopenia

Poland, Ukraine, Belgium, Bulgaria, South Africa, Netherlands, New Zealand, Singapore, Australia, Slovakia, Czechia
Amgen

Completed

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura

Thrombocytopenia in Pediatric Subjects With Immune Idiopathic Thrombocytopenic Purpura ITP

United States, Canada, Australia, Spain
Fujian Medical University Union Hospital
The Affiliated Hospital Of Guizhou Medical University; The Second Hospital... and other collaborators

Recruiting

Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment

China
Hutchmed

Recruiting

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Pathologic Processes | Immune System Diseases | Autoimmune Diseases | Hematologic Diseases | Hemorrhage | Hemorrhagic Disorders | Thrombotic Microangiopathies | Purpura | Purpura, Thrombocytopenic | Skin Manifestations | Thrombocytopenia | Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia | Blood Coagulation... and other conditions

United States, Spain, Germany, Australia, Norway
Novartis Pharmaceuticals

Completed

Drug Use Investigation for REVOLADE (ITP)

Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline

Completed

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopaenic, Idiopathic

Italy, Germany, Hong Kong, Korea, Republic of, United States, Pakistan, Russian Federation, India, Czech Republic, Hungary, France
GlaxoSmithKline

Completed

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopaenic, Idiopathic

Thailand, Korea, Republic of, United Kingdom, New Zealand, Germany, Greece, Hong Kong, Pakistan, Poland, Romania, Russian Federation, Slovenia, Taiwan
Peking University People's Hospital

Recruiting

Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia

Immune Thrombocytopenia
Peking University People's Hospital

Recruiting

The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Yin Jie

Recruiting

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Immune Thrombocytopenia

China
Sobi, Inc.

Completed

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Immune Thrombocytopenia

United States
Sobi, Inc.

Active, not recruiting

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Immune Thrombocytopenia

United States, France, Germany, Hungary, Poland, Russian Federation, Turkey, Ukraine, United Kingdom
Oscotec Inc.

Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

United States, Greece, Korea, Republic of, Poland, Spain
Ming Hou

Completed

The Serum Lipid Profiles in ITP: a Retrospective Study

Immune Thrombocytopenia

China
Peking University People's Hospital
Beijing Tongren Hospital; Beijing Hospital; Navy General Hospital, Beijing

Unknown

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Hospital; Navy General Hospital...

Unknown

A Study of ATRA in the Treatment of ITP

Immune Thrombocytopenia

China
Peking University People's Hospital

Unknown

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Unknown

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Immune Thrombocytopenia

China
Shandong University
The Affiliated Hospital of Qingdao University; Yantai Yuhuangding Hospital

Unknown

Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Shandong University

Completed

The Study of Different Dose Rituximab in the Treatment of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Weill Medical College of Cornell University
Children's Hospital of Orange County

Completed

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Immune Thrombocytopenia

United States
Shandong University

Unknown

A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) (ITP)

Immune Thrombocytopenia

China
Shandong University
Shandong Provincial Hospital; The First Affiliated Hospital of Dalian Medical...

Completed

An Investigation of rhTPO With Different Frequencies in the Management of ITP

Immune Thrombocytopenia

China
Shandong University
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences; Shenzhen Second People's Hospital and other collaborators

Withdrawn

High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

Immune Thrombocytopenia

China
Shandong University

Withdrawn

A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Immune Thrombocytopenia

China
Shandong University
Qingdao University; Shandong Provincial Hospital; Qianfoshan Hospital; Anhui Medical...

Completed

Caffeic Acid Tablets as a Second-line Therapy for ITP

Immune Thrombocytopenia

China
Eisai Inc.

Completed

A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects

Idiopathic Thrombocytopenia Purpura

United States
GlaxoSmithKline

Completed

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Purpura, Thrombocytopaenic, Idiopathic

United States, Australia, New Zealand
Institute of Hematology & Blood Diseases Hospital

Recruiting

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Connective Tissue Diseases | Autoantibodies | Immune Thrombocytopenia (ITP) | Evan Syndrome

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Primary Immune Thrombocytopenic Purpura

China
Novartis Pharmaceuticals

Completed

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP (TAPER)

Immune Thrombocytopenic Purpura (ITP)

Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
Institute of Hematology & Blood Diseases Hospital
Novartis; The Second Hospital of Hebei Medical University; Henan Cancer Hospital and other collaborators

Completed

to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

Chronic HBV Infection | Thrombocytopenia Purpura

China
Eisai Inc.

Completed

Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects

Purpura, Thrombocytopenic, Idiopathic | Chronic Thrombocytopenia | Acute Idiopathic Thrombocytopenic Purpura

Netherlands
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Immune Thrombocytopenia
Peking University People's Hospital

Not yet recruiting

The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia
Peking University People's Hospital

Not yet recruiting

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Jena University Hospital
Novartis; Amgen; Grifols Biologicals, LLC; argenx; Swedish Orphan Biovitrum; University...

Recruiting

ITP Registry and Accompanying Biospecimen Collection (ITP-Registry)

Immune Thrombocytopenia

Germany
Shandong University

Recruiting

A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Immune Thrombocytopenia

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Immune Thrombocytopenia

China
Shandong University

Recruiting

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Immune Thrombocytopenia

China
Centre Hospitalier Universitaire Dijon

Recruiting

Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP) (PTI Fc)

Immune Thrombocytopenia

France
Qidong Gaitianli Medicines Co., Ltd
Huazhong University of Science and Technology

Active, not recruiting

The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

China
Bioverativ, a Sanofi company

Completed

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Purpura, Thrombocytopenic, Idiopathic

United Kingdom, United States, Germany

Clinical Trials on Immune Thrombocytopenia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations